AORT
Artivion, Inc.
NYSE · Healthcare · Medical - Devices · US
$25.51
−0.45%0
Insider buys (3m)
6
Insider sells (3m)
-$3.0M
Net value (3m)
+26.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 20, 2026 | Mackin James P · officer: President & CEO | Sale | 70,000 | $29 |
| Aug 17, 2026 | GREEN ANDREW M · officer: SVP, Regulatory and Quality | Sale | 616 | $29 |
| Aug 17, 2026 | Berry Lance A · officer: EVP, COO, CFO & Treasurer | Sale | 715 | $29 |
| Aug 12, 2026 | Holloway Jean F · officer: SVP, General Counsel | Sale | 977 | $28 |
| Jun 15, 2026 | GREEN ANDREW M · officer: SVP, Regulatory and Quality | M-Exempt | 14,001 | $18 |
| Jun 15, 2026 | GREEN ANDREW M · officer: SVP, Regulatory and Quality | Sale | 30,000 | $21 |
| Jun 15, 2026 | GREEN ANDREW M · officer: SVP, Regulatory and Quality | M-Exempt | 30,000 | $11 |
| Jun 15, 2026 | GREEN ANDREW M · officer: SVP, Regulatory and Quality | Sale | 14,001 | $21 |
| May 20, 2026 | Burbank Jeffrey H · director | A-Award | 7,576 | $0.00 |
| May 20, 2026 | Borgstrom Marna P · director | A-Award | 7,576 | $0.00 |
| May 20, 2026 | Bullock James · director | A-Award | 7,576 | $0.00 |
| May 20, 2026 | Hoff Elizabeth A · director | A-Award | 7,576 | $0.00 |
| May 20, 2026 | BEVEVINO DANIEL J · director | A-Award | 7,576 | $0.00 |
| May 20, 2026 | Salveson Jon W · director | A-Award | 7,576 | $0.00 |
| May 20, 2026 | ACKERMAN THOMAS F · director | A-Award | 7,576 | $0.00 |
| May 20, 2026 | SEMEDO ANTHONY B. · director | A-Award | 7,576 | $0.00 |
| May 19, 2026 | Borgstrom Marna P · director | A-Award | 7,850 | $0.00 |
| Mar 4, 2026 | Holloway Jean F · officer: SVP, General Counsel | Sale | 8,962 | $38 |
| Mar 4, 2026 | Holloway Jean F · officer: SVP, General Counsel | Sale | 3,843 | $38 |
| Mar 4, 2026 | Berry Lance A · officer: EVP, COO, CFO & Treasurer | A-Award | 40,874 | $0.00 |
| Mar 4, 2026 | Holloway Jean F · officer: SVP, General Counsel | A-Award | 27,795 | $0.00 |
| Mar 4, 2026 | Stanton Marshall S. · officer: SVP, Clinical & MD Affair | Sale | 2,149 | $38 |
| Mar 4, 2026 | Horton Amy · officer: VP, Chief Accounting Officer | Sale | 901 | $38 |
| Mar 4, 2026 | Mackin James P · officer: President & CEO | A-Award | 116,948 | $0.00 |
| Mar 4, 2026 | Berry Lance A · officer: EVP, COO, CFO & Treasurer | Sale | 6,316 | $38 |
| Mar 4, 2026 | Mackin James P · officer: President & CEO | Sale | 17,887 | $38 |
| Mar 4, 2026 | Horton Amy · officer: VP, Chief Accounting Officer | A-Award | 7,475 | $0.00 |
| Mar 4, 2026 | Davis John E · officer: Chief Commercial Officer | A-Award | 28,845 | $0.00 |
| Mar 4, 2026 | Stanton Marshall S. · officer: SVP, Clinical & MD Affair | A-Award | 21,838 | $0.00 |
| Mar 4, 2026 | Davis John E · officer: Chief Commercial Officer | Sale | 4,573 | $38 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 20, 2026